Clinical value of ambulatory blood pressure monitoring

G. Mancia, C. Santucciu, L. Ulian, M. Gelosa, M. R. Rivolta, R. Sega

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

This report reviews the evidence for and against clinical use of ambulatory blood pressure monitoring (ABPM) on a large scale. Such monitoring is supported by a number of data, among which is that the end-organ damage associated with hypertension correlates more with 24-h average blood pressure than with clinic blood pressure, the correlation becoming even closer with addition of blood pressure variability values. However the evidence thus far collected is largely cross-sectional. Furthermore, ABPM devices have limited accuracy and the procedure has a high cost. Therefore, while prospective studies on the prognostic value of ambulatory blood pressure are awaited, use of this approach should be restricted to a limited number of clinical circumstances (e.g., identification of white-coat hypertension) and used only in specialized centers.

Original languageEnglish
JournalJournal of Cardiovascular Pharmacology
Volume23
Issue numberSUPPL. 5
Publication statusPublished - 1994

Fingerprint

Ambulatory Blood Pressure Monitoring
Blood Pressure
White Coat Hypertension
Prospective Studies
Hypertension
Costs and Cost Analysis
Equipment and Supplies

Keywords

  • ABPM
  • End-organ damage
  • Hypertension

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology

Cite this

Mancia, G., Santucciu, C., Ulian, L., Gelosa, M., Rivolta, M. R., & Sega, R. (1994). Clinical value of ambulatory blood pressure monitoring. Journal of Cardiovascular Pharmacology, 23(SUPPL. 5).

Clinical value of ambulatory blood pressure monitoring. / Mancia, G.; Santucciu, C.; Ulian, L.; Gelosa, M.; Rivolta, M. R.; Sega, R.

In: Journal of Cardiovascular Pharmacology, Vol. 23, No. SUPPL. 5, 1994.

Research output: Contribution to journalArticle

Mancia, G, Santucciu, C, Ulian, L, Gelosa, M, Rivolta, MR & Sega, R 1994, 'Clinical value of ambulatory blood pressure monitoring', Journal of Cardiovascular Pharmacology, vol. 23, no. SUPPL. 5.
Mancia G, Santucciu C, Ulian L, Gelosa M, Rivolta MR, Sega R. Clinical value of ambulatory blood pressure monitoring. Journal of Cardiovascular Pharmacology. 1994;23(SUPPL. 5).
Mancia, G. ; Santucciu, C. ; Ulian, L. ; Gelosa, M. ; Rivolta, M. R. ; Sega, R. / Clinical value of ambulatory blood pressure monitoring. In: Journal of Cardiovascular Pharmacology. 1994 ; Vol. 23, No. SUPPL. 5.
@article{2bb83efa3e74494e9b006c579e82d635,
title = "Clinical value of ambulatory blood pressure monitoring",
abstract = "This report reviews the evidence for and against clinical use of ambulatory blood pressure monitoring (ABPM) on a large scale. Such monitoring is supported by a number of data, among which is that the end-organ damage associated with hypertension correlates more with 24-h average blood pressure than with clinic blood pressure, the correlation becoming even closer with addition of blood pressure variability values. However the evidence thus far collected is largely cross-sectional. Furthermore, ABPM devices have limited accuracy and the procedure has a high cost. Therefore, while prospective studies on the prognostic value of ambulatory blood pressure are awaited, use of this approach should be restricted to a limited number of clinical circumstances (e.g., identification of white-coat hypertension) and used only in specialized centers.",
keywords = "ABPM, End-organ damage, Hypertension",
author = "G. Mancia and C. Santucciu and L. Ulian and M. Gelosa and Rivolta, {M. R.} and R. Sega",
year = "1994",
language = "English",
volume = "23",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL. 5",

}

TY - JOUR

T1 - Clinical value of ambulatory blood pressure monitoring

AU - Mancia, G.

AU - Santucciu, C.

AU - Ulian, L.

AU - Gelosa, M.

AU - Rivolta, M. R.

AU - Sega, R.

PY - 1994

Y1 - 1994

N2 - This report reviews the evidence for and against clinical use of ambulatory blood pressure monitoring (ABPM) on a large scale. Such monitoring is supported by a number of data, among which is that the end-organ damage associated with hypertension correlates more with 24-h average blood pressure than with clinic blood pressure, the correlation becoming even closer with addition of blood pressure variability values. However the evidence thus far collected is largely cross-sectional. Furthermore, ABPM devices have limited accuracy and the procedure has a high cost. Therefore, while prospective studies on the prognostic value of ambulatory blood pressure are awaited, use of this approach should be restricted to a limited number of clinical circumstances (e.g., identification of white-coat hypertension) and used only in specialized centers.

AB - This report reviews the evidence for and against clinical use of ambulatory blood pressure monitoring (ABPM) on a large scale. Such monitoring is supported by a number of data, among which is that the end-organ damage associated with hypertension correlates more with 24-h average blood pressure than with clinic blood pressure, the correlation becoming even closer with addition of blood pressure variability values. However the evidence thus far collected is largely cross-sectional. Furthermore, ABPM devices have limited accuracy and the procedure has a high cost. Therefore, while prospective studies on the prognostic value of ambulatory blood pressure are awaited, use of this approach should be restricted to a limited number of clinical circumstances (e.g., identification of white-coat hypertension) and used only in specialized centers.

KW - ABPM

KW - End-organ damage

KW - Hypertension

UR - http://www.scopus.com/inward/record.url?scp=0028659157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028659157&partnerID=8YFLogxK

M3 - Article

VL - 23

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - SUPPL. 5

ER -